Sonneveld, P., Dimopoulos, M. A., Boccadoro, M., Quach, H., Ho, P. J., Beksac, M., . . . Moreau, P. (2024). Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma. The New England journal of medicine, 390(4), 301-313. https://doi.org/10.1056/NEJMoa2312054
Citace podle Chicago (17th ed.)Sonneveld, Pieter, et al. "Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma." The New England Journal of Medicine 390, no. 4 (2024): 301-313. https://doi.org/10.1056/NEJMoa2312054.
Citace podle MLA (9th ed.)Sonneveld, Pieter, et al. "Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma." The New England Journal of Medicine, vol. 390, no. 4, 2024, pp. 301-313, https://doi.org/10.1056/NEJMoa2312054.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..